IDR 1002
£85.00 1mg
Innate defence regulator peptide.
IDR 1002 is a synthetic host defense peptide derivative with strong anti-inflammatory properties which was identified from a library of bactenecin derivatives. IDR 1002 is protective against the Gram-negative bacterial pathogen Escherichia coli with chemokine induction by IDR 1002 being mediated through a Gi-coupled receptor and the PI3K, NF-kappaB, and MAPK signalling pathways. IDR 1002 suppresses in vitro inflammatory responses in murine monocyte/macrophage cells challenged with TLR4 and TLR2 agonists, and reduces airway hyperresponsiveness and inflammation in a house dust mite challenged model of airway inflammation.
Please contact us for availability.
Additional information
Other Names | Innate defense regulator peptide 1002 |
---|---|
Three Letter Sequence | H-Val-Gln-Arg-Trp-Leu-Ile-Val-Trp-Arg-Ile-Arg-Lys-NH2 |
Molecular Weight | 1652.06 |
Molecular Formula | C79H130N26O13 |
Sequence | VQRWLIVWRIRK-NH2 |
Solubility | Soluble in water |
Appearance | Freeze dried solid |
Storage | Store dry, frozen and in the dark |
Purity | >95% by HPLC |
Modifications | C terminal amide |
Searchable Words | AM-320, IDR 1002, 1224095-25-3, VQRWLIVWRIRK-NH2, Innate defense regulator peptide 1002, AM320 |